世界のNGSベース診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global NGS Based Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4143
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、NGSベース診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（DNAシーケンシング、RNAシーケンシング、全ゲノムシーケンシング、全エクソームシーケンシング、その他）、用途別市場規模（病院、診療所、学術/研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・NGSベース診断の市場動向
・企業の競争状況、市場シェア
・NGSベース診断の種類別市場規模（DNAシーケンシング、RNAシーケンシング、全ゲノムシーケンシング、全エクソームシーケンシング、その他）
・NGSベース診断の用途別市場規模（病院、診療所、学術/研究機関）
・NGSベース診断の北米市場規模2016-2027（アメリカ、カナダ）
・NGSベース診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・NGSベース診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・NGSベース診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・NGSベース診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Janssen、Roche、Qiagen、ThermoFisher Scientific、Oxford Gene Technology、Illumina、Pacific Biosciences、Paradigm Diagnostics、Innogene Kalbiotech、Admera Health、AITbiotech、Centogene、Phalanx Biotech Group、iGenomX）
・結論

Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.
North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.

Market Analysis and Insights: Global NGS Based Diagnostics Market
The global NGS Based Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NGS Based Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NGS Based Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NGS Based Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NGS Based Diagnostics market.

Global NGS Based Diagnostics Scope and Market Size
NGS Based Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NGS Based Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other

Segment by Application
Hospitals
Clinics
Academics/Research Institutions

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
ThermoFisher Scientific
Oxford Gene Technology
Centogene

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS Based Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 DNA Sequencing
1.2.3 RNA Sequencing
1.2.4 Whole Genome Sequencing
1.2.5 Whole Exome Sequencing
1.2.6 Other
1.3 Market by Application
1.3.1 Global NGS Based Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academics/Research Institutions
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global NGS Based Diagnostics Market Perspective (2016-2027)
2.2 NGS Based Diagnostics Growth Trends by Regions
2.2.1 NGS Based Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 NGS Based Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 NGS Based Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 NGS Based Diagnostics Industry Dynamic
2.3.1 NGS Based Diagnostics Market Trends
2.3.2 NGS Based Diagnostics Market Drivers
2.3.3 NGS Based Diagnostics Market Challenges
2.3.4 NGS Based Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top NGS Based Diagnostics Players by Revenue
3.1.1 Global Top NGS Based Diagnostics Players by Revenue (2016-2021)
3.1.2 Global NGS Based Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global NGS Based Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by NGS Based Diagnostics Revenue
3.4 Global NGS Based Diagnostics Market Concentration Ratio
3.4.1 Global NGS Based Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS Based Diagnostics Revenue in 2020
3.5 NGS Based Diagnostics Key Players Head office and Area Served
3.6 Key Players NGS Based Diagnostics Product Solution and Service
3.7 Date of Enter into NGS Based Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 NGS Based Diagnostics Breakdown Data by Type
4.1 Global NGS Based Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global NGS Based Diagnostics Forecasted Market Size by Type (2022-2027)

5 NGS Based Diagnostics Breakdown Data by Application
5.1 Global NGS Based Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global NGS Based Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America NGS Based Diagnostics Market Size (2016-2027)
6.2 North America NGS Based Diagnostics Market Size by Type
6.2.1 North America NGS Based Diagnostics Market Size by Type (2016-2021)
6.2.2 North America NGS Based Diagnostics Market Size by Type (2022-2027)
6.2.3 North America NGS Based Diagnostics Market Size by Type (2016-2027)
6.3 North America NGS Based Diagnostics Market Size by Application
6.3.1 North America NGS Based Diagnostics Market Size by Application (2016-2021)
6.3.2 North America NGS Based Diagnostics Market Size by Application (2022-2027)
6.3.3 North America NGS Based Diagnostics Market Size by Application (2016-2027)
6.4 North America NGS Based Diagnostics Market Size by Country
6.4.1 North America NGS Based Diagnostics Market Size by Country (2016-2021)
6.4.2 North America NGS Based Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe NGS Based Diagnostics Market Size (2016-2027)
7.2 Europe NGS Based Diagnostics Market Size by Type
7.2.1 Europe NGS Based Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe NGS Based Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe NGS Based Diagnostics Market Size by Type (2016-2027)
7.3 Europe NGS Based Diagnostics Market Size by Application
7.3.1 Europe NGS Based Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe NGS Based Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe NGS Based Diagnostics Market Size by Application (2016-2027)
7.4 Europe NGS Based Diagnostics Market Size by Country
7.4.1 Europe NGS Based Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe NGS Based Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific NGS Based Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific NGS Based Diagnostics Market Size by Type
8.2.1 Asia-Pacific NGS Based Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific NGS Based Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific NGS Based Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific NGS Based Diagnostics Market Size by Application
8.3.1 Asia-Pacific NGS Based Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific NGS Based Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific NGS Based Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific NGS Based Diagnostics Market Size by Region
8.4.1 Asia-Pacific NGS Based Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific NGS Based Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America NGS Based Diagnostics Market Size (2016-2027)
9.2 Latin America NGS Based Diagnostics Market Size by Type
9.2.1 Latin America NGS Based Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America NGS Based Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America NGS Based Diagnostics Market Size by Type (2016-2027)
9.3 Latin America NGS Based Diagnostics Market Size by Application
9.3.1 Latin America NGS Based Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America NGS Based Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America NGS Based Diagnostics Market Size by Application (2016-2027)
9.4 Latin America NGS Based Diagnostics Market Size by Country
9.4.1 Latin America NGS Based Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America NGS Based Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa NGS Based Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa NGS Based Diagnostics Market Size by Type
10.2.1 Middle East & Africa NGS Based Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa NGS Based Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa NGS Based Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa NGS Based Diagnostics Market Size by Application
10.3.1 Middle East & Africa NGS Based Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa NGS Based Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa NGS Based Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa NGS Based Diagnostics Market Size by Country
10.4.1 Middle East & Africa NGS Based Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa NGS Based Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Janssen
11.1.1 Janssen Company Details
11.1.2 Janssen Business Overview
11.1.3 Janssen NGS Based Diagnostics Introduction
11.1.4 Janssen Revenue in NGS Based Diagnostics Business (2016-2021)
11.1.5 Janssen Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche NGS Based Diagnostics Introduction
11.2.4 Roche Revenue in NGS Based Diagnostics Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen NGS Based Diagnostics Introduction
11.3.4 Qiagen Revenue in NGS Based Diagnostics Business (2016-2021)
11.3.5 Qiagen Recent Development
11.4 ThermoFisher Scientific
11.4.1 ThermoFisher Scientific Company Details
11.4.2 ThermoFisher Scientific Business Overview
11.4.3 ThermoFisher Scientific NGS Based Diagnostics Introduction
11.4.4 ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2016-2021)
11.4.5 ThermoFisher Scientific Recent Development
11.5 Oxford Gene Technology
11.5.1 Oxford Gene Technology Company Details
11.5.2 Oxford Gene Technology Business Overview
11.5.3 Oxford Gene Technology NGS Based Diagnostics Introduction
11.5.4 Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2016-2021)
11.5.5 Oxford Gene Technology Recent Development
11.6 Illumina
11.6.1 Illumina Company Details
11.6.2 Illumina Business Overview
11.6.3 Illumina NGS Based Diagnostics Introduction
11.6.4 Illumina Revenue in NGS Based Diagnostics Business (2016-2021)
11.6.5 Illumina Recent Development
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Details
11.7.2 Pacific Biosciences Business Overview
11.7.3 Pacific Biosciences NGS Based Diagnostics Introduction
11.7.4 Pacific Biosciences Revenue in NGS Based Diagnostics Business (2016-2021)
11.7.5 Pacific Biosciences Recent Development
11.8 Paradigm Diagnostics
11.8.1 Paradigm Diagnostics Company Details
11.8.2 Paradigm Diagnostics Business Overview
11.8.3 Paradigm Diagnostics NGS Based Diagnostics Introduction
11.8.4 Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2016-2021)
11.8.5 Paradigm Diagnostics Recent Development
11.9 Innogene Kalbiotech
11.9.1 Innogene Kalbiotech Company Details
11.9.2 Innogene Kalbiotech Business Overview
11.9.3 Innogene Kalbiotech NGS Based Diagnostics Introduction
11.9.4 Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2016-2021)
11.9.5 Innogene Kalbiotech Recent Development
11.10 Admera Health
11.10.1 Admera Health Company Details
11.10.2 Admera Health Business Overview
11.10.3 Admera Health NGS Based Diagnostics Introduction
11.10.4 Admera Health Revenue in NGS Based Diagnostics Business (2016-2021)
11.10.5 Admera Health Recent Development
11.11 AITbiotech
11.11.1 AITbiotech Company Details
11.11.2 AITbiotech Business Overview
11.11.3 AITbiotech NGS Based Diagnostics Introduction
11.11.4 AITbiotech Revenue in NGS Based Diagnostics Business (2016-2021)
11.11.5 AITbiotech Recent Development
11.12 Centogene
11.12.1 Centogene Company Details
11.12.2 Centogene Business Overview
11.12.3 Centogene NGS Based Diagnostics Introduction
11.12.4 Centogene Revenue in NGS Based Diagnostics Business (2016-2021)
11.12.5 Centogene Recent Development
11.13 Phalanx Biotech Group
11.13.1 Phalanx Biotech Group Company Details
11.13.2 Phalanx Biotech Group Business Overview
11.13.3 Phalanx Biotech Group NGS Based Diagnostics Introduction
11.13.4 Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2016-2021)
11.13.5 Phalanx Biotech Group Recent Development
11.14 iGenomX
11.14.1 iGenomX Company Details
11.14.2 iGenomX Business Overview
11.14.3 iGenomX NGS Based Diagnostics Introduction
11.14.4 iGenomX Revenue in NGS Based Diagnostics Business (2016-2021)
11.14.5 iGenomX Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global NGS Based Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of DNA Sequencing
Table 3. Key Players of RNA Sequencing
Table 4. Key Players of Whole Genome Sequencing
Table 5. Key Players of Whole Exome Sequencing
Table 6. Key Players of Other
Table 7. Global NGS Based Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global NGS Based Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global NGS Based Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global NGS Based Diagnostics Market Share by Regions (2016-2021)
Table 11. Global NGS Based Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global NGS Based Diagnostics Market Share by Regions (2022-2027)
Table 13. NGS Based Diagnostics Market Trends
Table 14. NGS Based Diagnostics Market Drivers
Table 15. NGS Based Diagnostics Market Challenges
Table 16. NGS Based Diagnostics Market Restraints
Table 17. Global NGS Based Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global NGS Based Diagnostics Market Share by Players (2016-2021)
Table 19. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS Based Diagnostics as of 2020)
Table 20. Ranking of Global Top NGS Based Diagnostics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by NGS Based Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players NGS Based Diagnostics Product Solution and Service
Table 24. Date of Enter into NGS Based Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global NGS Based Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global NGS Based Diagnostics Revenue Market Share by Type (2016-2021)
Table 28. Global NGS Based Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global NGS Based Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global NGS Based Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global NGS Based Diagnostics Revenue Market Share by Application (2016-2021)
Table 32. Global NGS Based Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global NGS Based Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America NGS Based Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America NGS Based Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America NGS Based Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America NGS Based Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America NGS Based Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America NGS Based Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe NGS Based Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe NGS Based Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe NGS Based Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe NGS Based Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe NGS Based Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe NGS Based Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific NGS Based Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific NGS Based Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific NGS Based Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific NGS Based Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific NGS Based Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific NGS Based Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America NGS Based Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America NGS Based Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America NGS Based Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America NGS Based Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America NGS Based Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America NGS Based Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa NGS Based Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa NGS Based Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa NGS Based Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa NGS Based Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa NGS Based Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa NGS Based Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Janssen Company Details
Table 65. Janssen Business Overview
Table 66. Janssen NGS Based Diagnostics Product
Table 67. Janssen Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 68. Janssen Recent Development
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche NGS Based Diagnostics Product
Table 72. Roche Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 73. Roche Recent Development
Table 74. Qiagen Company Details
Table 75. Qiagen Business Overview
Table 76. Qiagen NGS Based Diagnostics Product
Table 77. Qiagen Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 78. Qiagen Recent Development
Table 79. ThermoFisher Scientific Company Details
Table 80. ThermoFisher Scientific Business Overview
Table 81. ThermoFisher Scientific NGS Based Diagnostics Product
Table 82. ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 83. ThermoFisher Scientific Recent Development
Table 84. Oxford Gene Technology Company Details
Table 85. Oxford Gene Technology Business Overview
Table 86. Oxford Gene Technology NGS Based Diagnostics Product
Table 87. Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 88. Oxford Gene Technology Recent Development
Table 89. Illumina Company Details
Table 90. Illumina Business Overview
Table 91. Illumina NGS Based Diagnostics Product
Table 92. Illumina Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 93. Illumina Recent Development
Table 94. Pacific Biosciences Company Details
Table 95. Pacific Biosciences Business Overview
Table 96. Pacific Biosciences NGS Based Diagnostics Product
Table 97. Pacific Biosciences Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 98. Pacific Biosciences Recent Development
Table 99. Paradigm Diagnostics Company Details
Table 100. Paradigm Diagnostics Business Overview
Table 101. Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 102. Paradigm Diagnostics Recent Development
Table 103. Innogene Kalbiotech Company Details
Table 104. Innogene Kalbiotech Business Overview
Table 105. Innogene Kalbiotech NGS Based Diagnostics Product
Table 106. Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 107. Innogene Kalbiotech Recent Development
Table 108. Admera Health Company Details
Table 109. Admera Health Business Overview
Table 110. Admera Health NGS Based Diagnostics Product
Table 111. Admera Health Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 112. Admera Health Recent Development
Table 113. AITbiotech Company Details
Table 114. AITbiotech Business Overview
Table 115. AITbiotech NGS Based Diagnostics Product
Table 116. AITbiotech Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 117. AITbiotech Recent Development
Table 118. Centogene Company Details
Table 119. Centogene Business Overview
Table 120. Centogene NGS Based Diagnostics Product
Table 121. Centogene Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 122. Centogene Recent Development
Table 123. Phalanx Biotech Group Company Details
Table 124. Phalanx Biotech Group Business Overview
Table 125. Phalanx Biotech Group NGS Based Diagnostics Product
Table 126. Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 127. Phalanx Biotech Group Recent Development
Table 128. iGenomX Company Details
Table 129. iGenomX Business Overview
Table 130. iGenomX NGS Based Diagnostics Product
Table 131. iGenomX Revenue in NGS Based Diagnostics Business (2016-2021) & (US$ Million)
Table 132. iGenomX Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NGS Based Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. DNA Sequencing Features
Figure 3. RNA Sequencing Features
Figure 4. Whole Genome Sequencing Features
Figure 5. Whole Exome Sequencing Features
Figure 6. Other Features
Figure 7. Global NGS Based Diagnostics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Academics/Research Institutions Case Studies
Figure 11. NGS Based Diagnostics Report Years Considered
Figure 12. Global NGS Based Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global NGS Based Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global NGS Based Diagnostics Market Share by Regions: 2020 VS 2027
Figure 15. Global NGS Based Diagnostics Market Share by Regions (2022-2027)
Figure 16. Global NGS Based Diagnostics Market Share by Players in 2020
Figure 17. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS Based Diagnostics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by NGS Based Diagnostics Revenue in 2020
Figure 19. Global NGS Based Diagnostics Revenue Market Share by Type (2016-2021)
Figure 20. Global NGS Based Diagnostics Revenue Market Share by Type (2022-2027)
Figure 21. North America NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America NGS Based Diagnostics Market Share by Type (2016-2027)
Figure 23. North America NGS Based Diagnostics Market Share by Application (2016-2027)
Figure 24. North America NGS Based Diagnostics Market Share by Country (2016-2027)
Figure 25. United States NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe NGS Based Diagnostics Market Share by Type (2016-2027)
Figure 29. Europe NGS Based Diagnostics Market Share by Application (2016-2027)
Figure 30. Europe NGS Based Diagnostics Market Share by Country (2016-2027)
Figure 31. Germany NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific NGS Based Diagnostics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific NGS Based Diagnostics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific NGS Based Diagnostics Market Share by Region (2016-2027)
Figure 41. China NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America NGS Based Diagnostics Market Share by Type (2016-2027)
Figure 49. Latin America NGS Based Diagnostics Market Share by Application (2016-2027)
Figure 50. Latin America NGS Based Diagnostics Market Share by Country (2016-2027)
Figure 51. Mexico NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa NGS Based Diagnostics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa NGS Based Diagnostics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa NGS Based Diagnostics Market Share by Country (2016-2027)
Figure 57. Turkey NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE NGS Based Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Janssen Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 62. Qiagen Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 63. ThermoFisher Scientific Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 64. Oxford Gene Technology Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 65. Illumina Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 66. Pacific Biosciences Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 67. Paradigm Diagnostics Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 68. Innogene Kalbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 69. Admera Health Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 70. AITbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 71. Centogene Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 72. Phalanx Biotech Group Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 73. iGenomX Revenue Growth Rate in NGS Based Diagnostics Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Global PCR and NGS-Based Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z4474 2021年4月 90Pages
QYResearch社発行の本調査資料では、PCR＆NGSベース分子診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（バイオマーカー検出、血液サンプル検査、その他）、用途別市場規模（病院、学術/研究機関、その他）、主要地域別市場規模（北米、ア...

世界のDNAプローブベース診断市場規模・現状・予測（2021年-2027年）

Global DNA Probes Based Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z1943 2021年4月 92Pages
QYResearch社発行の本調査資料では、DNAプローブベース診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ゲノムプローブ、cDNAプローブ、オリゴヌクレオチドプローブ）、用途別市場規模（感染症、がん、遺伝的素因、アイデンティティ/法医...

世界のヒトマイクロバイオーム治療薬・診断市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Based Drugs and Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z2951 2021年4月 95Pages
QYResearch社発行の本調査資料では、ヒトマイクロバイオーム治療薬・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療、診断）、用途別市場規模（臨床研究所、病院、手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のがん診断市場規模・現状・予測（2021年-2027年）

Global Cancer Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z1065 2021年4月 96Pages
QYResearch社発行の本調査資料では、がん診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プラットフォームベース、機器ベース）、用途別市場規模（乳がん、肺がん、大腸がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界のPCRベース検査市場規模・現状・予測（2021年-2027年）

Global PCR-Based Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4479 2021年4月 125Pages
QYResearch社発行の本調査資料では、PCRベース検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アナライザー/機器、キット/パネル）、用途別市場規模（診断＆治療、遺伝子検査、癌、進化生物学、遺伝子指紋、法医学研究、COVID-19、...

世界のGAS咽頭炎診断市場規模・現状・予測（2021年-2027年）

Global GAS Pharyngitis Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z2485 2021年4月 98Pages
QYResearch社発行の本調査資料では、GAS咽頭炎診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（迅速検査キット、培養検査、PCR検査）、用途別市場規模（医師クリニック、診断研究所、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の大型トラック用オンボード診断システム市場規模・現状・予測（2021年-2027年）

Global Heavy Trucks On-board Diagnostics System Market Size, Status and Forecast 2021-2027
QYR2104Z2753 2021年4月 126Pages
QYResearch社発行の本調査資料では、大型トラック用オンボード診断システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハンドヘルド型スキャンツール、携帯型ツール、PC型スキャンツール）、用途別市場規模（ガソリン式自動車、ディーゼル式自...

世界のRSV診断市場規模・現状・予測（2021年-2027年）

Global RSV Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z5092 2021年4月 92Pages
QYResearch社発行の本調査資料では、RSV診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（キット及びアッセイ、器具、その他）、用途別市場規模（病院＆診療所、臨床検査室、在宅医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のDNA検査/診断市場規模・現状・予測（2021年-2027年）

Global DNA Testing/Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z1947 2021年4月 126Pages
QYResearch社発行の本調査資料では、DNA検査/診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（PCRベース診断、ISH診断、NGSDNA診断）、用途別市場規模（病院、医学研究、薬理ゲノミクス診断検査）、主要地域別市場規模（北米、ア...

世界のPCRベース腸疾患検査市場規模・現状・予測（2021年-2027年）

Global PCR-based Enteric Disease Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4478 2021年4月 157Pages
QYResearch社発行の本調査資料では、PCRベース腸疾患検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アナライザー/機器、キット/パネル）、用途別市場規模（クロストリジウム・ディフィシル、カンピロバクター症、コレラ、腸管出血性大腸菌...

世界のシングルセルゲノムシーケンシング技術市場規模・現状・予測（2021年-2027年） Single-Cell Genome Sequencing Technology is a new technology to amplify and sequence the whole genome at the single cell level. The principle is to amplify a small amount of genomic DNA from isolated single cells, obtain high-coverage complete genomes, and then perform high-throughput sequencing to …
世界のがんゲノム配列決定市場規模・現状・予測（2021年-2027年） Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells. It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumo…
世界のメタゲノムシーケンス市場規模・現状・予測（2021年-2027年） Metagenomics is the study of genetic material recovered directly from environmental samples. The broad field may also be referred to as environmental genomics, ecogenomics or community genomics. As the price of DNA sequencing continues to fall, metagenomics now allows microbial ecology to be investi…
世界のターゲットRNAシーケンシング市場規模・現状・予測（2021年-2027年） Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene express…
世界の第3世代シーケンス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Third-Generation Sequencing Market The global Third-Generation Sequencing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…